Señales en vivo de BION.SW | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 11:31):

Stats
Volumen de hoy	51 457.00
Volumen promedio	67 720.00
Capitalización de mercado	2.22B
EPS	CHF0 ( 2024-04-26 )
Próxima fecha de ganancias	( CHF0 ) 2024-07-26
Last Dividend	CHF0 ( N/A )
Next Dividend	CHF0 ( N/A )
P/E	-10.73
ATR14	CHF0.0690 (0.17%)

Volumen Correlación

Largo: -0.19 (neutral)

Corto: -0.86 (strong negative)

Signal:(55.315) Neutral

BB Biotech AG Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BB Biotech AG Correlación - Moneda/Commodity

0.53
( weak )

0.65
( weak )

0.00
( neutral )

0.49
( neutral )

-0.33
( neutral )

0.01
( neutral )

BB Biotech AG Finanzas

Annual	2023
Ingresos:	CHF-199.57M
Beneficio Bruto:	CHF-199.57M (100.00 %)
EPS:	CHF-3.77

FY	2023
Ingresos:	CHF-199.57M
Beneficio Bruto:	CHF-199.57M (100.00 %)
EPS:	CHF-3.77

FY	2022
Ingresos:	CHF-351.23M
Beneficio Bruto:	CHF-351.23M (100.00 %)
EPS:	CHF-6.50

FY	2021
Ingresos:	CHF-396.22M
Beneficio Bruto:	CHF0.00 (0.00 %)
EPS:	CHF-7.31

Financial Reports:

No articles found.

BB Biotech AG

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.